Cargando…
Subconjunctival dexamethasone implant for non-necrotizing scleritis
BACKGROUND: The purpose of this study is to report the management of non-necrotizing anterior scleritis with a single-dose subconjunctival 0.7 mg dexamethasone implant (Ozurdex®, Allergan, Inc., CA, USA). Six patients with clinical diagnosis of non-necrotizing anterior scleritis (diffuse, sectorial,...
Autores principales: | Nascimento, Heloisa, França, Maíra, García, Luciana Guadalupe, Muccioli, Cristina, Belfort, Rubens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605070/ https://www.ncbi.nlm.nih.gov/pubmed/23514443 http://dx.doi.org/10.1186/1869-5760-3-7 |
Ejemplares similares
-
Subconjunctival dirofilariasis mimicking scleritis: First report from Western India
por: Sangit, Vishram A, et al.
Publicado: (2012) -
Diffuse uveitis and chorioretinal changes after yellow fever vaccination: a re-emerging epidemic
por: Marinho, Paula M., et al.
Publicado: (2019) -
Necrotic choroidal melanoma masquerading as scleritis
por: Putri, Christine A, et al.
Publicado: (2020) -
Fungal scleritis masquerading as surgically induced necrotizing scleritis: a case report
por: Sahu, Srikant Kumar, et al.
Publicado: (2013) -
Efficacy and tolerability of a fixed-dose moxifloxacin – dexamethasone formulation for topical prophylaxis in LASIK: a comparative, double-masked clinical trial
por: Campos, Mauro, et al.
Publicado: (2008)